Wiesner, N.
Dutescu, R. M.
Uthoff, D.
Kottek, A.
Reim, M.
Schrage, N. http://orcid.org/0000-0002-6695-3440
Article History
Received: 26 January 2019
Revised: 1 April 2019
Accepted: 2 May 2019
First Online: 30 May 2019
Compliance with ethical standards
: This was a retrospective study of a prospectively collected registry of patients treated for corrosive chemical eye burns in the authors’ institutions. All patient-specific identifying information was removed from the registry and replaced with identifying numbers only. No patient-specific identifying information is presented here. For this reason, the authors’ institutions do not require approval by an Institutional Review Board or Human Subjects Committee. As the study was performed in Germany, considerations relating to US HIPPA regulations do not apply.
: • Honoraria for speaking at symposia: Novartis, Allergan, Ursapharm• Employment or consultation: ACTO e.V., P&G, Prevor Int.• Support from P&G, PREVOR, Omnivision, BMBF, AIF research projects